191 related articles for article (PubMed ID: 35187707)
21. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme.
Ikeda M; Kihara A; Kariya Y; Lee YM; Igarashi Y
Biochem Biophys Res Commun; 2005 Apr; 329(2):474-9. PubMed ID: 15737611
[TBL] [Abstract][Full Text] [Related]
23. S1P metabolism in cancer and other pathological conditions.
Leong WI; Saba JD
Biochimie; 2010 Jun; 92(6):716-23. PubMed ID: 20167244
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine-1-phosphate metabolism: A structural perspective.
Pulkoski-Gross MJ; Donaldson JC; Obeid LM
Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
[TBL] [Abstract][Full Text] [Related]
26. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
[TBL] [Abstract][Full Text] [Related]
27. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma.
Miura K; Nagahashi M; Prasoon P; Hirose Y; Kobayashi T; Sakata J; Abe M; Sakimura K; Matsuda Y; Butash AL; Katsuta E; Takabe K; Wakai T
Hepatol Res; 2021 May; 51(5):614-626. PubMed ID: 33586816
[TBL] [Abstract][Full Text] [Related]
29. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
[TBL] [Abstract][Full Text] [Related]
30. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
31. Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption.
Vutukuri R; Brunkhorst R; Kestner RI; Hansen L; Bouzas NF; Pfeilschifter J; Devraj K; Pfeilschifter W
J Neurochem; 2018 Jan; 144(2):172-185. PubMed ID: 29023711
[TBL] [Abstract][Full Text] [Related]
32. Re-configuration of sphingolipid metabolism by oncogenic transformation.
Don AS; Lim XY; Couttas TA
Biomolecules; 2014 Mar; 4(1):315-53. PubMed ID: 24970218
[TBL] [Abstract][Full Text] [Related]
33. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase.
Facchinetti MM; Beuret C; Marquez MG; Sterin-Speziale N
Biol Neonate; 2003; 84(3):243-51. PubMed ID: 14504448
[TBL] [Abstract][Full Text] [Related]
34. Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation.
Wakashima T; Abe K; Kihara A
J Biol Chem; 2014 Sep; 289(36):24736-48. PubMed ID: 25049234
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
Maceyka M; Payne SG; Milstien S; Spiegel S
Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
Maceyka M; Milstien S; Spiegel S
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S272-6. PubMed ID: 18987387
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again.
Oskouian B; Saba J
Cell Cycle; 2007 Mar; 6(5):522-7. PubMed ID: 17361098
[TBL] [Abstract][Full Text] [Related]
38. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus regulates bioactive sphingolipids.
Machesky NJ; Zhang G; Raghavan B; Zimmerman P; Kelly SL; Merrill AH; Waldman WJ; Van Brocklyn JR; Trgovcich J
J Biol Chem; 2008 Sep; 283(38):26148-60. PubMed ID: 18644793
[TBL] [Abstract][Full Text] [Related]
40. Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei.
Custódio R; McLean CJ; Scott AE; Lowther J; Kennedy A; Clarke DJ; Campopiano DJ; Sarkar-Tyson M; Brown AR
Mol Microbiol; 2016 Dec; 102(6):1004-1019. PubMed ID: 27632710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
